爬一下新闻有两家
1. NHK，我看不懂日文所以看英文
https://tinyurl.com/f9wfh4ax
"So Daiichi Sankyo is considering holding the trial in a noninferiority-test
format to confirm that its vaccine can produce antibodies in acceptable
amounts compared to other vaccines already in use."
似乎确实有考虑免疫桥接(用抗体来比较)
2. 日经，我也是看英文
https://tinyurl.com/pkhsvxd6
"So Daiichi Sankyo's next trial is expected to test non-inferiority, meaning
that the goal is to show the company's new treatment matches or outperforms
those made by Pfizer and Moderna